2018

• Prasad on Medicine. Medscape.

• When Do We Need Randomized Controlled Trials, and When Can We Manage Without Them? Medscape.2018

• FDA's Genomic Screening Approval Blurs Research and Practice. Medscape.2018

• Calling Out the FDA's 'We Don't Regulate Medicine' Mantra. Medscape.2018

• 'Twitter Cheerleaders': A Megaphone for Bad Science. Medscape. 2018

• 21st Century Physician: Triaging the Tsunami of Medical Information. Medscape. 2018

2017

• Few people actually benefit from ‘breakthrough’ cancer immunotherapy. STAT

• PSA screening is still a bad deal. STAT

2016

• NEJM foolish stance on data sharing

• The Case for Rationing Cancer Drugs (STAT)

• Let NPs practice independently (STAT)

• Why a Cancer Moonshot is Unlikely to Give us a Cure.  (Washington Post)

• Don't believe what you read about Medical Errors (STAT)

2015

• Five Years of Cancer Drug Approvals: Most Cost too Much and Give us Too Little. (RAPS invited rebuttal)

• Why Are Most Cancer Drugs So Expensive. (Guest of Allen Frances at the Huffington Post)

• Perspective on the Selective reporting of primary, secondary endpoints common in randomized oncology trials. (HemOnc Today)

• The Folly of Big Science Prizes. (The New York Times)

• When Doctors Rely on Promise Instead of Proof. (Baltimore Sun)

• Why Lisa Rosenbaum Gets Conflict of Interest Policies Wrong (Lown Institute)

2014

• Let's Take a Close Look at PARADIGM-HF (CardioExchange)

• And, the redacted discussion (CardioExchange)

2013

• President Bush's Cardiac Stent (Washington Post)

• How Should We Weight Conflicting Advice About our Health (Footnote1.com)

2012

• Clinical Researchers Meet the Physician Scientists (Kevin MD)

• Work Hour Reform is a Moral Imperative (Kevin MD)